All Stories

  1. Spontaneous, isolated, and gaze-evoked ocular flutter: A rare case report
  2. Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays
  3. Reduced expression of L-selectin in T-cells correlates with relative lymphocyte increase in patients with RRMS treated with natalizumab - functional implication towards PML risk
  4. Psychological distress symptoms and illness perception in patients with epilepsy in Northwest Greece
  5. Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research
  6. Reasons for Failed trials of Disease-modifying Treatments for Alzheimer Disease and their Contribution in Recent Research
  7. Depression and quality of life in patients with epilepsy in Northwest Greece
  8. pentoxifylline to the reduction in the elastic modulus of human red blood cells
  9. The effectiveness of hydrokinesiotherapy on postural balance of hemiplegic patients after stroke: a systematic review and meta-analysis
  10. The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials
  11. Disk Herniation or ependymoma recurrence?
  12. The effect of menarche age, parity and lactation on bone mineral density in premenopausal ambulatory multiple sclerosis patients
  13. Alzheimer and glaucoma associations
  14. AUTOIMMUNE DISEASES IN MS PATIENTS
  15. Risk factors for cognitive dysfunction in CKD and hypertensive subjects
  16. Capturing the elasticity and morphology of live fibroblast cell cultures during degradation with atomic force microscopy
  17. High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid
  18. Body Composition in Ambulatory Patients With Multiple Sclerosis
  19. HLA associations with multiple sclerosis in Greece
  20. IC-P-022: Reversible dementia as first symptom of multiple myeloma: A case report
  21. Bone mineral density in ambulatory patients with multiple sclerosis
  22. Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece
  23. Perimetric and peri-papillary nerve fibre layer thickness findings in multiple sclerosis
  24. MRI Deterioration in Herpes Simplex Encephalitis Despite Clinical Recovery
  25. Agenesis of the corpus callosum associated with narcolepsy–cataplexy
  26. Periventricular nodular heterotopia and epilepsy
  27. Thrombosis and Recanalization of Straight Sinus
  28. Multiple-Organ Cavernous Hemangiomas Involving Brain, Skin, and Lung
  29. Isolated headache as the sole manifestation of dural sinus thrombosis
  30. Lateral medullary ischaemic events in young adults with hypoplastic vertebral artery
  31. Brainstem mass and testicular tuberculosis
  32. Cognitive Impairment in Patients with Neuropathic Pain
  33. Neurological manifestations of connective tissue diseases mimicking multiple sclerosis
  34. Burden of Illness in Painful Diabetic Peripheral Neuropathy
  35. VERTEBRAL ARTERY HYPOPLASIA: A PREDISPOSING FACTOR FOR POSTERIOR CIRCULATION STROKE?
  36. Patient Compliance With SSRIs and Gabapentin in Painful Diabetic Neuropathy
  37. Multiple sclerosis associated with systemic sclerosis
  38. Increased sensitivity to N-methyl-d-aspartate receptor-induced excitotoxicity in cerebellar granule cells from interleukin-1 receptor type I-deficient mice
  39. Erratum to “PO glycoprotein peptides 56–71 and 180–199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreading” [J. Neuroimmunol. 114 (2001) 106]
  40. P0 glycoprotein peptides 56–71 and 180–199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreading
  41. HIGH INFLAMMATION AND MILD DEMYELINATION IN THE PERIPHERAL NERVOUS SYSTEM INDUCED BY AN INTRANEURAL INJECTION OF RR INTERLEUKIN-4
  42. Enhancement of Acute Phase and Inhibition of Chronic Phase of Experimental Autoimmune Neuritis in Lewis Rats by Intranasal Administration of Recombinant Mouse Interleukin 17: Potential Immunoregulatory Role
  43. Rolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis rats
  44. Intranasal Administration of Recombinant Mouse Interleukin-12 Increases Inflammation and Demyelination in Chronic Experimental Autoimmune Neuritis in Lewis Rats
  45. Protective Effect of Rolipram in Experimental Autoimmune Neuritis: Protection is Associated with Down-Regulation of IFN-γ and Inflammatory Chemokines as Well as Up-Regulation of IL-4 in Peripheral Nervous System
  46. Increased IL-1β, IL-8, and IL-17 mRNA Expression in Blood Mononuclear Cells Observed in a Prospective Ischemic Stroke Study
  47. Dynamics of production of MIP-1α, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats
  48. Local effects of recombinant rat interleukin-6 on the peripheral nervous system
  49. Inflammation and Severe Demyelination in the Peripheral Nervous System Induced by the Intraneural Injection of Recombinant Mouse Interleukin-12
  50. High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases
  51. Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin‐6
  52. Nasal Administration of Recombinant Rat IL-4 Ameliorates Ongoing Experimental Autoimmune Neuritis and Inhibits Demyelination